ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Oct 31, 2013
The Valuentum Dividend Cushion Predicts CONSOL’s Dividend Cut
The Valuentum Dividend Cushion continues to showcase its efficacy as a dividend growth investing tool.
Oct 25, 2013
Surveying 3Q Performance from Big Pharma: Bristol-Myers, Eli Lilly, and AbbVie
Let’s take a look at the third-quarter performance of a few pharmaceutical firms.
Oct 25, 2013
Dividend Increases for the Week Ending October 25
Let's take a look at dividend increases for the week ending October 25.
Oct 25, 2013
The Tale of Three Valuentum Buying Index Ratings of 9
Let’s take a look at how three firms with near-perfect VBI ratings performed in their respective third quarters: Deluxe, NASDAQ OMX, and USG.
Oct 18, 2013
Facebook: The New Internet?
Let’s take a look at what we think Facebook might be in a decade or so.
Oct 18, 2013
Philip Morris' Operating Income Growth Stalls in 3Q; Learn About Altria’s Hidden $21.6 Billion Potential Cash Load
Philip Morris continues to battle declining cigarette volumes. We prefer Altria and not for a reason that is well known.
Oct 18, 2013
PPG Posts Record Third Quarter Results; Our Favorite Idea in the Chemicals Industry
Let’s examine PPG’s third-quarter performance. This chemicals firm is one for the radar.
Oct 14, 2013
Safeway Misses But Will Sell Unprofitable Chicago Business
Safeway continues to focus on asset rationalization, but we’re not fans of the company at current levels.
Oct 10, 2013
Yum! Brands’ Problems Extend Beyond China
Weak US same-store sales growth only makes matters worse at Yum! Brands.
Oct 10, 2013
What Baseball Taught Investors About Stock Valuation
Let’s flash back to the miracle summer of 1961…


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.